In contrast, cytosolic ALK fusion proteins, such as NPM1-ALK and EML4-ALK, are constitutively active and common drivers of tumor progression in anaplastic large-cell lymphoma and non-small cell lung cancer1,8–10. This evidence concerns the gene ALK and neoplasm.